Current Trends and Future Directions in Psoriatic Disease
National Psoriasis Foundation Commit to Cure honorees discuss treatment advances, patient advocacy work, and dermatology-rheumatology collaboration.
National Psoriasis Foundation Commit to Cure honorees discuss treatment advances, patient advocacy work, and dermatology-rheumatology collaboration.
Supported by an independent educational grant from Genmab US, Inc. and AbbVie This live roundtable discussion will center on the advancing field of bispecific antibodies…
In this interview, Dr Vishal Patel discusses recent advances in high-risk cutaneous squamous cell carcinoma, focusing on gene expression profiling and promising treatment approaches.
Thursday, June 20, 2024 9:40 – 10:40 AM CT CME/CNE Virtual Join us for a symposium on major depressive disorder (MDD) designed to encourage the…
A recent study spotlights an opportunity for interdisciplinary collaboration between dermatologists and orthodontists.
The 17th Annual Hematologic Malignancies Demystified returns in 2025. Access our virtual CME conference and earn CME/CE credits with our renowned faculty. Led by conference…
Dr Alexandra Golant discusses managing multiple conditions in a 17-year-old African American waitress, highlighting the complexities of treating moderate-to-severe atopic dermatitis alongside severe acne and…
VELA is the first phase 3 hidradenitis suppurativa trial to evaluate HiSCR75 as the primary end point.
A recent study highlighted growing concerns within the dermatological community regarding an increase in treatment-resistant fungal strains. Researchers from The University of Texas Health Science…
Bristol Myers Squibb announced 70% of patients maintained significant improvement after 4 years with no new safety concerns.
Supported by an independent educational grant from CymaBay Therapeutics. Patients with primary biliary cholangitis (PBC) experience a disease burden that is often underappreciated. Do you…